# Deka Research & Development Corp.

- Location (FDA's records): Manchester, NH
- FDA decisions: 13 (1984–2025): 13 510(k) clearances
- Names in FDA's records: Deka Research & Development Corp. (10); DEKA Research & Development (3)
- Product codes: LDR (3), FKX (2), FRN (2), QJY (2), FPA (1), QFG (1), IMK (1), FIG (1)
- Predicates its devices cite: 14 (4 its own); citations of its devices by later devices: 11 (4 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Baxter Healthcare Corp: 3 (https://510kreport.com/company/baxter-healthcare)
- Deka Research and Development: 2 (https://510kreport.com/company/deka-research-and-development)
- Rocky Mountain Research, Inc.: 1 (https://510kreport.com/company/rocky-mountain-research)
- Medivice Systems, Ltd.: 1 (https://510kreport.com/company/medivice-systems)
- Smiths Medical MD, Inc.: 1 (https://510kreport.com/company/smiths-medical-md)
- Fresenius Medical Care North America: 1 (https://510kreport.com/company/fresenius-medical-care-north-america)

## Firms that cite its devices most
- Deka Research and Development: 5 (https://510kreport.com/company/deka-research-and-development)
- Mobius Mobility: 1 (https://510kreport.com/company/mobius-mobility)
- Deka R&D Corp: 1 (https://510kreport.com/company/deka-r-d)

## Its most-cited devices
- K190182: Unity Subcutaneous Delivery System for Remodulin (2019), cited by 2
- K191313: Unity Subcutaneous Infusion System for Remodulin (2020), cited by 2
- K250930: twiist system (2025), cited by 1
- K172601: Next Generation iBOT (2018), cited by 1
- K153760: Volumetric Infusion Controller (2016), cited by 1
- K124018: Amia Automated PD System (2013), cited by 1

## Recent decisions
- K250930: twiist system (Apr 2, 2025)
- K250357: RemunityPRO™ Pump for Remodulin® (treprostinil) Injection (Mar 11, 2025)
- K243354: Remunity System (Nov 27, 2024)
- K191313: Unity Subcutaneous Infusion System for Remodulin (Feb 21, 2020)
- K190182: Unity Subcutaneous Delivery System for Remodulin (May 6, 2019)
- K172601: Next Generation iBOT (Mar 2, 2018)
- K153760: Volumetric Infusion Controller (Oct 3, 2016)
- K124018: Amia Automated PD System (Jun 14, 2013)

Source page: https://510kreport.com/company/deka-research-development